SCHEMBL8621728

SCHEMBL8621728

CC(N)C(Cc1ccc(-c2ccccc2)c(F)c1)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDFT1 P37268 6/20 0.47
PTGS1 P23219 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
PTGS2 P35354 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
FABP2 P12104 1/20 0.44
TSHR P16473 1/20 0.44
AKR1C4 P17516 1/20 0.44
ADRA2B P18089 1/20 0.44
CHRM3 P20309 1/20 0.44
HTR2C P28335 1/20 0.44
DRD3 P35462 1/20 0.44
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8624732 0.91 FDFT1 (0.41) FDFT1PTGS1MEN1KMT2APTGS2
SCHEMBL8625042 0.86 FDFT1 (0.62) FDFT1PTGS1MEN1KMT2APTGS2
SCHEMBL8621294 0.86 FDFT1 (0.62) FDFT1PTGS1MEN1KMT2APTGS2
SCHEMBL8619570 0.85 APEX1 (0.43) FDFT1MAPTCNR1CNR2
SCHEMBL8625176 0.84 SLC6A3 (0.46) FDFT1CNR1CNR2
SCHEMBL8623070 0.82 FDFT1 (0.53) FDFT1CYP1A2CNR1CNR2
SCHEMBL8620804 0.82 FDFT1 (0.53) FDFT1CYP1A2CNR1CNR2
SCHEMBL8623834 0.82 FDFT1 (0.53) FDFT1CYP1A2CNR1CNR2
SCHEMBL8625643 0.82 FDFT1 (0.53) FDFT1CYP1A2CNR1CNR2
SCHEMBL8623149 0.81 PNMT (0.46) FDFT1PTGS2CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5777150-A Substituted amic acid derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-07-07 US disclosed
EP-0611749-B1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMA CO LTD (JP) 1997-10-22 EP disclosed
US-5616803-A EXHIBIT SQUALENE SYNTHASE-INHIBITORY ACTIVITIES; USEFUL IN TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA, HYPERLIPEMIA AND ARTERIOSCLEROSIS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-04-01 US disclosed
US-5606101-A INTERMEDIATES FOR SQUALENE SYNTHASE INHIBITORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-02-25 US disclosed
US-5488149-A SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-01-30 US disclosed
EP-0611749-A1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-24 EP disclosed